Go Paperless to Accelerate Clinical Trial Processes @ Double Speed
In clinical trial processes, every trial phase includes various steps, decisions, and results. To do it right, all these need to be inked, approved, filed and submitted to appropriate parties. MSB Docs is easing it out particularly with the expansion of electronic and digital signatures. Book a demo to know-how.
Paperwork Challenges in Clinical Trials
In addition to getting every document signed and approved during each trial, there are other challenges too:
storing detailed records of each document transaction during trial.
patient recruitment and retention process.
data spread across too many disparate data sources.
Why Paperless Clinical Trials?
- Ubiquitous access to approved documents enables continuous quality checks.
- It becomes easy to sign documents simultaneously while studying quality metrics.
- Each document can be accessed by authorized people so risk-based monitoring is completely safe on going paperless.
- Anywhere, any device accessibility of documents made CRO oversighting easier than ever.
How MSB Docs Eliminates the Ever-burdening Paperwork
MSB Docs Key Features:
Electronic & Digital Signature
Moving processes away from paper directly impacts operational efficiency and bottom-line performance. As a result:
- Drugs receive faster approvals and hit the market on time.
- Resources are re-allocated to necessary tasks rather than handling paperwork
- Faster payout approvals for CROs
- Documents are tamper-proof and audit trails exist for each document transaction.
Impact of using eSignatures & digital signatures in Clinical Trials
Reduction in average time to sign clinical trials document
Approx. savings in paper-related costs in the first year of paperless clinical trials
MSB Docs Adherence to Compliance and Standards
Every technology that undergirds e-signature or digital signatures must adhere to international, published standards. MSB Docs – smart document solution is amongst those solutions that are fully compliant with federal Electronic Signatures in Global and National Commerce Act (ESIGN), the state-level Uniform Electronic Transactions Act (UETA), and 21 CFR Part 11 regulations outlined by U.S. Food and Drug Administration (FDA).
Reach Out to us & Focus Less on Administration – More on Trials